What We're Reading: Most Expensive Medicare Drugs
December 23rd 2015What we're reading, December 23, 2015: CMS releases data on the most expensive Medicare drugs, while HHS reports strong enrollment numbers on HealthCare.gov, and Hillary Clinton outlines a plan to spend $20 billion on Alzheimer's disease research.
NPC's Michael Ciarametaro Discusses the Move to Bundled Payments
December 22nd 2015As the healthcare system moves to an environment of value-based payment, bundled payments could become the next step in healthcare transformation. However, there are both opportunities and risks in this form of value-based payment, explained Michael Ciarametaro, MBA, director of research at the National Pharmaceutical Council, at the ISPOR 20th Annual International Meeting.
What We're Reading: US Task Force Releases Statin Use Recommendations
December 22nd 2015What we're reading, December 22, 2015: experts recommend using statins in adults between the ages of 40 years and 75 years; Republicans and Democrats are equally concerned about rising healthcare costs; and Martin Shkreli now fired as CEO of a second company.
What We're Reading: Taxpayers Spending Millions on Expensive Generic Drugs
December 18th 2015What we're reading, December 18, 2015: HHS report finds generic drug prices rising faster than inflation; UnitedHealthcare's real-time drug approval tool; and government overcharged by private Medicare Advantage plans.
What We're Reading: Congress Deals 3 Blows to the ACA
December 17th 2015What we're reading, December 17, 2015: Congress is expected to pass a spending plan that includes 3 changes to the Affordable Care Act; a new analysis estimates 2016 premiums for marketplace plans will increase 11%; and one-third of Americans die from cardiovascular disease.
What We're Reading: Rethinking What We Know About Healthcare Costs
December 16th 2015What we're reading, December 16, 2015: a new study casts doubt on what experts thought they knew about healthcare costs; unprecedented interest in health insurance coverage has prompted the government to extend the deadline for full-year 2016 coverage; and a law to create multi-state health plans won't reach it's 2017 goal.
What We're Reading: Last-Minute Rush for ACA Coverage
December 15th 2015What we're reading, December 15, 2015: call centers overwhelmed by last-minute rush for health insurance enrollment; AstraZeneca exploring deal with Acerta Pharma; and despite near universal health insurance coverage in Massachusetts, patients have access issues.
What We're Reading: Public Health Initiatives Are Underfunded in the US
December 14th 2015What we're reading, December 14, 2015: public health initiatives are underfunded despite being a big return on investment; the FDA repeatedly approved the cancer drug Afinitor without proof it extended life; and a nurse may have exposed patients in a maternity wing to tuberculosis.
Leah Binder to Discuss Patient Safety and Hospital Quality in December 15 Tweetchat
December 10th 2015On Tuesday, December 15, from 11 am to noon EST, The American Journal of Managed Care will host a tweetchat with Leah Binder, MA, MGA, president and CEO of The Leapfrog Group, about hospital quality ratings, patient safety, and healthcare outcomes.
What We're Reading: 1 Million New Sign-Ups for ACA Insurance
December 10th 2015What we're reading, December 10, 2015: the Affordable Care Act has signed up 1 million new enrollees; Medicare patients spend more on oral cancer drugs than food each year; and the CDC found life expectancy remains at 79 years for the third year in a row.
What We're Reading: Government Recovers $200 Million From State Health Exchanges
December 9th 2015What we're reading, December 9, 2015: the federal government recovered $200 million from state's whose health insurance exchanges faltered; drug cocktails are responsible for majority of drug overdose deaths in Massachusetts; and healthcare organizations are not confident in their ability to share patient data while protecting patient privacy.
What We're Reading: Continued Drug Pricing Scrutiny
December 7th 2015What we're reading, December 7, 2015: Mylan is subpoenaed over pricing of generic doxycycline antibiotic products; Congressional hearing this week on drug pricing controversy; new superbug on the rise; and Obamacare penalty for being uninsured may not be enough to get people to sign up.
What We're Reading: US Health Spending Increased 5.3% in 2014
December 3rd 2015What we're reading, December 3, 2015: health spending in the US topped $3 trillion in 2014; experts debate the true impact of proposed health insurer mega-mergers; and a survey finds ICD-10 transition has been mostly without trouble.
What We're Reading: Gilead Knew Sovaldi Price Was High
December 2nd 2015What we're reading, December 2, 2015: Gilead priced Sovaldi knowing the high cost would be a challenge for patients and payers; Senate Republicans will vote Thursday on Obamacare repeal and expect to get the needed votes; and a report calls for a better focus on women's health.
What We're Reading: $1 Alternative to Pricey Daraprim
December 1st 2015What we're reading, December 1, 2015: $1 alternative to Daraprim being made available; over-the-counter medications are convenient and affordable but have their own dangers; and an analysis looks at the reasons why prescription drugs are so much more expensive in the US.
What We're Reading: Spanish HealthCare.gov Lags in Sign-ups
November 30th 2015What we're reading, November 30, 2015: the Spanish language HealthCare.gov is lagging in sign-ups; the overall federal insurance exchange has fewer preferred provider organizations; and many Americans don't understand why they need the flu vaccine.